Related Experiment Video
Updated: Apr 12, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Novel CO2 removal device driven by a renal-replacement system without hemofilter. A first step experimental
Thomas Godet1, Alain Combes2, Elie Zogheib3
1General Intensive Care Unit, réanimation adultes et unité de soins continus, département d'anesthésie-réanimation, hôpital Estaing, CHU de Clermont-Ferrand, université Auvergne - Clermont-Ferrand 1, 63000 Clermont-Ferrand, France.
This study demonstrates a novel extracorporeal CO2 removal device effectively reduced carbon dioxide levels and corrected acidosis in pigs. The device shows promise for managing hypercapnia in critical care settings.
Area of Science:
- Critical Care Medicine
- Cardiovascular Physiology
- Biomedical Engineering
Background:
- Hypercapnia and acidosis are critical conditions requiring effective CO2 removal.
- Extracorporeal CO2 removal (ECCO2R) devices offer a potential solution for managing these conditions.
- Evaluating novel ECCO2R technologies is crucial for advancing patient care.
Purpose of the Study:
- To assess the technical effectiveness of a new extracorporeal CO2 removal device.
- To quantify the CO2 elimination capacity of the device under various operational parameters.
- To evaluate the impact of the device on blood gases and acid-base balance in an animal model.
Main Methods:
- A prospective animal study was conducted using five healthy adult female pigs.
- Hypercapnic pigs were connected to a low-flow CO2 removal device (PrismaLung) integrated with a CRRT platform.
- CO2 elimination was measured in vivo under varying blood flow rates, sweep gas flows, and oxygen concentrations.
Main Results:
- The device achieved CO2 removal rates between 35-75 mL/min.
- Increased blood and sweep gas flows enhanced CO2 removal efficiency.
- Significant reductions in partial pressure of carbon dioxide (PaCO2) and improvements in pH were observed, indicating effective acidosis correction.
Conclusions:
- The extracorporeal CO2 removal device, integrated with a Prismaflex platform, demonstrated technical efficacy.
- The device successfully reduced PaCO2 and ameliorated acidosis in hypercapnic pigs.
- Findings support the potential clinical utility of this novel ECCO2R technology.
More Related Videos
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis II: Procedure and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

